I have intermittent phantosmia, smelling smoke and detergent—what evaluation and management are recommended?

Evaluation and Management of Intermittent Phantosmia

You should begin with nasal endoscopy and standardized olfactory testing (UPSIT or Sniffin' Sticks), and only pursue MRI imaging if examination findings are abnormal, symptoms are progressive, or neurological signs are present. 1, 2

Initial Clinical Assessment

Your intermittent phantom smells (phantosmia) require a systematic evaluation to distinguish between peripheral sinonasal causes and central nervous system pathology:

Essential History Elements

• Recent viral illness: Post-infectious olfactory dysfunction, particularly following COVID-19, has become a leading cause of qualitative smell disorders including phantosmia 2, 3, 4
• Medication review: Polypharmacy (≥5 prescription medications) increases odds of phantosmia by 70%, with antidiabetic agents, statins, and proton pump inhibitors specifically associated with 74-88% greater odds 5
• Toxic exposures: Occupational or environmental chemical exposures can cause permanent olfactory damage 6
• Neurological symptoms: Unilateral phantosmia with associated neurological deficits suggests temporal lobe pathology requiring urgent evaluation 1, 2
• Trauma history: Head injury is a common cause of post-traumatic phantosmia 2, 3

Required Physical Examination

• Rigid nasal endoscopy: Essential to identify sinonasal inflammatory disease, polyps, or tumors that may cause conduction loss 1, 2
• Standardized olfactory testing: UPSIT or Sniffin' Sticks provides objective characterization of olfactory function and distinguishes phantosmia from parosmia 1, 2, 3

Imaging Decision Algorithm

Most patients with phantosmia do NOT require imaging unless specific red flags are present 1, 2:

Indications for MRI Orbits/Face/Neck (with and without contrast):

• Discordance between subjective symptoms and endoscopic findings 2
• Progressive or persistent symptoms without clear inflammatory cause 2
• Associated focal neurological signs suggesting CNS pathology 1, 2
• Unilateral phantosmia with ipsilateral olfactory loss (temporal lobe concern) 2
• No clear temporal relationship to viral infection 2

Role of CT Maxillofacial:

• Limited utility: Reserved specifically for evaluating facial fractures, paranasal sinus inflammatory disease, and bony anatomy 1, 2
• Not routinely indicated for olfactory evaluation 2

Avoid:

• CT head has no established role in olfactory evaluation 1, 2
• Vascular imaging is not indicated for phantosmia 2

Common Etiologies to Consider

Peripheral Causes:

• Post-viral olfactory dysfunction (including COVID-19) 2, 3, 4
• Chronic rhinosinusitis with nasal polyposis 1, 2
• Medication side effects (especially polypharmacy) 5
• Toxic chemical exposures 3, 6

Central Causes:

• Temporal lobe pathology (tumors, epilepsy) 1, 2
• Neurodegenerative disease (Alzheimer's, Parkinson's) 1, 2
• Psychiatric disorders 3, 7

Treatment Approach

For Post-Infectious Phantosmia:

Olfactory training is first-line therapy: Sniff four different strong-smelling substances for 20 seconds each, twice daily 2, 8, 3

Adjunctive intranasal corticosteroids: Fluticasone or mometasone may provide benefit for post-infectious olfactory dysfunction 8

Symptomatic Management:

• Topical nasal medications for persistent cases 2
• Address underlying psychiatric comorbidity if present 1, 3

Safety Counseling (Critical)

All patients with phantosmia require safety education 2:

• Install smoke and gas detectors immediately
• Monitor food expiration dates carefully
• Exercise caution with cooking practices
• Be vigilant about potential hazardous exposures

Follow-Up Protocol

• Re-evaluate at 1,3, and 6 months after initiating treatment 8
• Consider MRI only if symptoms persist beyond 6 months despite therapy or if new neurological symptoms develop 2, 8
• Refer to otolaryngology or specialized smell/taste clinic if no improvement after 3-6 months of conservative management 8

Critical Pitfalls to Avoid

• Do not assume simple phantosmia if temporal lobe symptoms are present: Olfactory hallucinations may indicate serious CNS disease requiring urgent neurological evaluation 1, 2
• Do not order imaging reflexively: Most phantosmia does not require advanced imaging unless clinical examination warrants it 1, 2
• Do not overlook medication review: Polypharmacy is a common and reversible cause 5
• Do not forget safety counseling: Patients with olfactory dysfunction are at risk for environmental hazards 2